when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Hematology · news · pharmadog

← back to Hematology

News · Hematology

411 stories

May 7, 26Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026onclive

May 7, 26Reigniting Your Curiosity During Fellowshiponclive

May 7, 26STAT+: FDA to reconsider treatment for rare cancer after its surprise rejectionstat

May 7, 26Opinion: Eugene Braunwald, ‘father of modern cardiology,’ told me he had two dreams. One came truestat

May 6, 26Dr McGregor on the DAD-IO Trial of Sacituzumab Govitecan and EV in Metastatic Urothelial Carcinomaonclive

May 6, 26Neoadjuvant T-DXd Followed by THP Improves RCB in HER2+ Breast Canceronclive

May 6, 26Dr Lee on Research Collaborations Studying PD-L1 as a Biomarker in NSCLConclive

May 6, 26Dr Chari on Frontline Combinations and Transplant Approaches in Multiple Myelomaonclive

May 6, 26Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Canceronclive

May 6, 26Dr Herrera on the Significance of the FDA Approval of Nivolumab Plus AVD for Classical Hodgkin Lymphomaonclive

May 6, 26Dr Sznol on Biomarkers of Response in Metastatic Melanomaonclive

May 6, 26Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipelinebiopharma dive

May 6, 26Transformational Utah Investment in Artificial Intelligence and Computing to Advance Health and Discoveryonclive

May 6, 26ASCO 2026 HR+ and HER2+ Breast Cancer Preview: Read up on the Insights to Know Before You Goonclive

May 6, 26Disease Assessment and Mutational Testing in Progressive CLLonclive

May 6, 26Clinical Scenario Presentation and Treatment Approach for Progressive Diseaseonclive

May 6, 26Dr Pant on the Mechanism of Action of Daraxonrasib in PDAConclive

May 5, 26Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic Canceronclive

May 5, 26Dr Pant on Managing Toxicities With Daraxonrasib in PDAConclive

May 5, 26Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer Congressonclive

May 5, 26The Type of Fat—Not the Amount—Fuels Pancreatic Canceronclive

May 5, 26Second life for gene therapy; Takeda Phase 2/3 win; UK cancer biotech's $83Mendpoints

May 5, 26Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCConclive

May 5, 26Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosisonclive

May 5, 26Vertex earnings get muted investor responsebiopharma dive

May 5, 26Cytokinetics heart drug scores in closely watched trialbiopharma dive

May 5, 26Coordinating Care in Multiple Myeloma Across Practice Settingsonclive

May 5, 26Cytospire hauls in $83M for a new type of T cell engagerbiopharma dive

May 1, 26Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlookbiopharma dive

May 1, 26STAT+: Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and morestat

← prevpage 13 of 14next →